Loading company…
Sebela Pharmaceuticals, of Roswell, US, develops gastroenterology and women's health drugs, including Tegoprazan for GERD.
Established in 2013 in Roswell, US, Sebela Pharmaceuticals develops prescription products in gastroenterology and women's health. Its core product is Tegoprazan, for gastroesophageal reflux disease (GERD), and its affiliate Braintree addresses gastrointestinal diseases. Sales go to healthcare providers, hospitals and clinics in the United States and selected international markets. An August 2013 funding round included DFW Capital and Altiva Capital alongside management, with financial terms not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in